| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |